Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	CASE_CONTROL	Chemotherapy	Drug	Race	TIMEPOINT	Tamoxyfen	Taxane
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	950167	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	971065	Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1002533	Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1092714	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1163159	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1164228	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1238646	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1255034	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1318176	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1330744	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1350405	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1354311	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1366679	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1414413	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1419581	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1428993	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1431978	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1450463	Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1451123	Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1452279	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1460324	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1476934	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1498496	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1510458	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1525636	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1540193	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1572089	Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1583418	Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1593277	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1614691	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1628015	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1633499	Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1646529	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1689473	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1697287	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1711999	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1714801	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1735899	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1747260	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1807058	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1814856	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1832785	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1842625	Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1855136	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1863835	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1892863	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1940787	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1951320	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1952477	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	1993833	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	2004887	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	2020048	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	2074036	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	2085633	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	2089432	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	2120463	Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	2147544	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	2160950	Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	2194005	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	2195379	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	2200101	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	2214867	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	2242562	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	2262215	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	2306025	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	2307414	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	2325886	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	2372184	Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	2394733	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	2407099	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	2465937	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	2477000	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	2490808	Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	2497971	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	2545824	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	2562719	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	2564089	Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	2575784	Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	2626489	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	2690905	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	2727785	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	2731145	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	2890647	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	2931653	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	2974713	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	3063473	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	3065212	Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	3155775	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	3265973	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	3315414	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	3315695	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	3413985	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	3442716	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	3459599	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	3466314	Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	3536269	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	3638770	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	3694159	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	4194607	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+H)+	4688666	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	6088	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	7299	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	7420	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	9010	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	10016	Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	10395	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	10848	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	11120	Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	11137	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	11357	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	11362	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	11534	Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	11597	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	11643	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	11745	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	11936	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	11960	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	11970	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	12132	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	12147	Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	12404	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	12424	Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	12591	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	12726	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	12755	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	12784	Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	12808	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	12812	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	12836	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	12997	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	13123	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	13322	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	13682	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	13812	Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	13981	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	14039	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	14047	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	14107	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	14203	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	14205	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	14342	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	14346	Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	14401	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	14512	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	14651	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	15242	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	15281	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	15415	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	15579	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	15637	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	15659	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	15971	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	16295	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	16604	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	17498	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	17585	Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	18137	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	18829	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	18912	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	18999	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	19250	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	19358	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	19470	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	19609	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	20143	Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	20196	Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	20287	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	20403	Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	20813	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	21633	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	21853	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	22158	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	22667	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	23039	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	23087	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	23139	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	23208	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	23461	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	23952	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	24103	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	24116	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	24137	Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	24348	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	24486	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	24896	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	25831	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	26217	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	26456	Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	28032	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	33999	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	34375	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	37094	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	42624	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	54400	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	56836	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+	86427	Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+		Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+		Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+		Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	VALINE (CAS# 72-18-4); (M+NA)+		Peak area	Control	Y	Exemestane	White	Baseline	N	Y